SCHEMBL481886

SCHEMBL481886

CN1CCCCC1CN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6778239 1.00
SCHEMBL4379139 0.98 CYP1A2 (0.59)
SCHEMBL172961 0.93
SCHEMBL1621133 0.93
SCHEMBL1371466 0.93
Hydrochloric Acid SCHEMBL34475098 0.91 CYP1A2 (0.45)
Hydrochloric Acid SCHEMBL30578093 0.91 CYP1A2 (0.45)
SCHEMBL35210875 0.82
SCHEMBL21738973 0.82
SCHEMBL35211119 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109081361-B Hierarchical porous EU-1 molecular sieve and preparation method thereof 中触媒新材料股份有限公司 2020-02-14 CN claimed
CN-108439428-B A kind of multi-stage porous ZSM-5 molecular sieve of P Modification and preparation method thereof 山东多友科技有限公司 2019-11-08 CN claimed
CN-109081361-A A kind of multi-stage porous EU-1 molecular sieve and preparation method thereof 中触媒新材料股份有限公司 2018-12-25 CN claimed
CN-108439428-A A kind of multi-stage porous ZSM-5 molecular sieve of P Modification and preparation method thereof 山东多友科技有限公司 2018-08-24 CN claimed
US-20090264411-A1 FUSED THIOPHENE DERIVATIVES AS MEK INHIBITORS UCB PHARMA S.A. (BE) 2009-10-22 US claimed
EP-1303489-A2 ALPHA,ALPHA-DIBROMO-ALPHA-CHLORO-ACETOPHENONES AS SYNTHONS GENEVA PHARMACEUTICALS, INC. (US) 2003-04-23 EP claimed
US-20020188130-A1 Alpha, alpha-dibromo-alpha-chloro-acetophenones as synthons RAY ANUP K (US) 2002-12-12 US claimed
US-6458957-B1 PROCESS FOR PREPARING AN AROMATIC CARBONYL COMPOUND, WHICH COMPRISES (A) CONVERTING AN .ALPHA.-CHLORO DERIVATIVE OF AN ACETOPHENONE COMPOUND TO DIBROMO-.ALPHA.-CHLORO ACETOPHENONE COMPOUND AND (B) REACTING THE GENEVA PHARMACEUTICALS, INC. 2002-10-01 US claimed
WO-2002004419-A2 α,α-DIBROMO-α-CHLORO-ACETOPHENONES AS SYNTHONS GENEVA PHARMACEUTICALS, INC. (US) 2002-01-17 WO claimed
WO-2026101698-A1 HEPCIDIN MIMETIC COMPOUNDS AND USES THEREOF PROTAGONIST THERAPEUTICS, INC. (US) 2026-05-15 WO disclosed
US-12612387-B2 RAS inhibitors and methods of using the same JAZZ PHARMACEUTICALS IRELAND LIMITED (IE) 2026-04-28 US disclosed
US-20260034107-A1 SUBSTITUTED FUSED IMIDAZOLE DERIVATIVES AND METHODS OF TREATING SICKLE CELL DISEASE AND RELATED COMPLICATIONS VTV THERAPEUTICS LLC (US) 2026-02-05 US disclosed
US-20260027090-A1 Methods of Inhibiting Osteoclastogenesis and Osteoclast Activity VTV THERAPEUTICS LLC (US) 2026-01-29 US disclosed
US-20250340563-A1 FUSED PYRIDAZINE DERIVATIVES AS NLRP3 INHIBITORS TAKEDA DEVELOPMENT CENTER AMERICAS, INC. 2025-11-06 US disclosed
US-6458957-B1 PROCESS FOR PREPARING AN AROMATIC CARBONYL COMPOUND, WHICH COMPRISES (A) CONVERTING AN .ALPHA.-CHLORO DERIVATIVE OF AN ACETOPHENONE COMPOUND TO DIBROMO-.ALPHA.-CHLORO ACETOPHENONE COMPOUND AND (B) REACTING THE GENEVA PHARMACEUTICALS, INC. 2002-10-01 US disclosed
US-6020379-A Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia CELL PATHWAYS, INC. (US) 2000-02-01 US disclosed
US-4089960-A Antiemetic, psychosomatic and antipsychotic heterocyclic pyridine carboxamides CIBA-GEIGY CORPORATION (US) 1978-05-16 US disclosed
US-3956363-A Substituted indenyl acetic acids MERCK & CO., INC. (US) 1976-05-11 US disclosed
US-3954852-A Indenylacetic acid compounds MERCK & CO., INC. (US) 1976-05-04 US disclosed
US-3932498-A ANTIINFLAMMATORY, ANTIPYRETICS, ANALGESICS MERCK & CO., INC. (US) 1976-01-13 US disclosed